Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease.
The effect of antigen challenge on the state of activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease (COPD) has been determined by measuring neutrophil superoxide anion formation. Prior to a seven-hour antigen challenge superoxide anion production by neutrophils from asymptomatic horses with COPD and normal horses in response to platelet activating factor (PAF) (with and without cytochalasin B), serum treated zymosan (STZ) and phorbol myristate acetate (PMA) was similar. Agonist-induced superoxide production by neutrophils from symptomatic COPD and normal horses remained unchanged five and 24 hours after antigen challenge. Interestingly, however, superoxide production by neutrophils from symptomatic COPD horses was significantly increased 24 hours after antigen challenge in the control samples for each agonist (basal superoxide production), a five-fold increase being measured in the presence of cytochalasin B. There was a small increase in superoxide production by neutrophils from normal horses but this only reached significance in one set of control samples. The change in activation state of circulating neutrophils during antigen challenge may facilitate the lung neutrophilia and subsequent tissue damage which occur in COPD.
Marr
K A
KA
Department of Veterinary Basic Sciences, Royal Veterinary College, North Mymms, Hertfordshire.
Foster
A P
AP
Lees
P
P
Cunningham
F M
FM
Page
C P
CP
D000818:Animals; D000941:Antigens / Q000494:pharmacology*; D003571:Cytochalasin B / Q000494:pharmacology; D006734:Horse Diseases / Q000097:blood* / Q000378:metabolism / Q000503:physiopathology*; D006736:Horses; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000503:physiopathology / Q000662:veterinary*; D018375:Neutrophil Activation / Q000187:drug effects*; D010972:Platelet Activating Factor / Q000494:pharmacology; D013481:Superoxides / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors; D015054:Zymosan / Q000494:pharmacology
D000941:Antigens; D010972:Platelet Activating Factor; D013481:Superoxides; D003571:Cytochalasin B; D015054:Zymosan; D013755:Tetradecanoylphorbol Acetate